Suchergebnisse - "Frisell, Thomas"

PubPharm (18)

1

Trajectories of cognitive processing speed and physical disability over 11 years following initiation of a first multiple sclerosis disease-modulating therapy

enthalten in: Journal of neurology, neurosurgery, and psychiatry | 2024

von Longinetti, E. | Englund, S. | Burman, J. | +13

2

Sustained Low Relapse Rate With Highly Variable B-Cell Repopulation Dynamics With Extended Rituximab Dosing Intervals in Multiple Sclerosis

enthalten in: Neurology(R) neuroimmunology & neuroinflammation | 2023

von Starvaggi Cucuzza, C. | Longinetti, E. | Ruffin, N. | +6

ErratumIn: Neurol Neuroimmunol Neuroinflamm. 2024 May;11(3):e200252. - PMID 38579190

3

Efficacy and Safety of Rituximab for New-Onset Generalized Myasthenia Gravis : The RINOMAX Randomized Clinical Trial

enthalten in: JAMA neurology | 2022

von Piehl, F. | Eriksson-Dufva, A. | Budzianowska, A. | +18

CommentIn: JAMA Neurol. 2022 Nov 1;79(11):1100-1102. - PMID 36121665

4

Effectiveness of baricitinib and tofacitinib compared with bDMARDs in RA : results from a cohort study using nationwide Swedish register data

enthalten in: Rheumatology (Oxford, England) | 2022

von Barbulescu, A. | Askling, J. | Chatzidionysiou, K. | +5

5

Comparison of treatment retention of originator vs biosimilar products in clinical rheumatology practice in Sweden

enthalten in: Rheumatology (Oxford, England) | 2022

von Di Giuseppe, D. | Lindstrom, U. | Bower, H. | +6

6

Safety and efficacy of rituximab versus dimethyl fumarate in patients with relapsing-remitting multiple sclerosis or clinically isolated syndrome in Sweden : a rater-blinded, phase 3, randomised controlled trial

enthalten in: The Lancet. Neurology | 2022

von Svenningsson, A. | Frisell, T. | Burman, J. | +20

CommentIn: Lancet Neurol. 2022 Aug;21(8):672-673. - PMID 35841895

7

Rituximab Infusion Timing, Cumulative Dose, and Hospitalization for COVID-19 in Persons With Multiple Sclerosis in Sweden

enthalten in: JAMA network open | 2021

von McKay, K. | Piehl, F. | Englund, S. | +4

8

Disease activity in pregnancy and postpartum in women with MS who suspended rituximab and natalizumab

enthalten in: Neurology(R) neuroimmunology & neuroinflammation | 2020

von Razaz, N. | Piehl, F. | Frisell, T. | +3

9

Comparison Between Rituximab Treatment for New-Onset Generalized Myasthenia Gravis and Refractory Generalized Myasthenia Gravis

enthalten in: JAMA neurology | 2020

von Brauner, S. | Eriksson-Dufva, A. | Hietala, M. | +3

10

Cancer Risk for Fingolimod, Natalizumab, and Rituximab in Multiple Sclerosis Patients

enthalten in: Annals of neurology | 2020

von Alping, P. | Askling, J. | Burman, J. | +13